| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4274807 | Urología Colombiana | 2015 | 12 Pages |
Abstract
The available evidence comparing neoadjuvant regimes such as gemcitabine-cisplatin vs methotrexate-vinblastine-adriamycin-cisplatin is limited and lacks randomised studies. The evidence provides similar results with both cancer neoadjuvant chemotherapy regimens.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
José Luis Poveda, RocÃo Arias Mutis, José Daza, Carlos Velásquez, Wilfredo Donoso, William Fajardo, Cesar González,